Scientists have successfully tested an injectable hydrogel that blocks sperm for at least two years, marking a significant advancement in non-hormonal male contraceptives. The hydrogel, when injected into the vas deferens—the duct that transports sperm—forms a barrier that prevents sperm from being released during ejaculation.
The study, which has shown encouraging safety and efficacy results, indicates that the hydrogel can be a long-acting, reversible, and non-surgical contraceptive option for men. Importantly, the material used in the hydrogel is biocompatible, reducing the risk of adverse reactions and making it potentially reversible by flushing the hydrogel out to restore fertility.
This innovative approach could provide a much-needed alternative to existing male contraceptive methods, such as condoms and vasectomies, which currently offer limited options. Researchers stress that further testing in human clinical trials is necessary before the product becomes publicly available, but the findings present real promise for expanding family planning options.
If successful in broader trials, this hydrogel could join the few male-targeted contraceptives on the market, potentially helping to rebalance contraceptive responsibility between genders.
Source: https:// – Courtesy of the original publisher.
